STAT Investigation: Troubled for-profit chains scrutinized on psychiatric hospital joint ventures

Dozens of nonprofits are turning to investor-owned chains to build new hospitals to manage a surge in patients with mental health crises.

July 8, 2024 Check out STAT+

Sponsored By

Andrew Spear for STAT STAT+ | Troubled for-profit chains are stealthily operating dozens of psychiatric hospitals under nonprofits' names With their own brands tarnished by legal problems, Acadia and UHS are piggybacking off nonprofit hospitals' strong local reputations. By Tara Bannow New study sparks debate about whether H5N1 virus in cows is adapted to better infect humans The study could stoke fears that H5N1 in cows is adapting to spread more easily in humans, but other research has yielded different results. By Megan Molteni STAT+ | Eli Lilly to acquire Morphic for $3.2 billion Lilly, flush with cash from sales of its blockbuster GLP-1-based treatments, has struck a number of deals and partnerships last year and this year. By Elaine Chen Andrew Harnik/Getty Images Opinion: EcoHealth Alliance: Covid's anti-science mob extracting its pound of flesh Organization with key roles in Covid, SARS, and other research faces NIH defunding: A First Opinion on the "conspiracy theorists are winning." By Peter Staley Bird flu snapshot: Live H5N1 virus grown from raw milk samples as Delaware moves to legalize its sale Weekly H5N1 update includes new data on pasteurized milk safety, and concern about avian flu virus in raw milk. By Megan Molteni STAT+ | Biden administration appeals jury finding in battle over patents for HIV prevention pills At issue are patents for the lucrative HIV prevention drugs Truvada and Descovy, along with the federal government's role in their creation. By Ed Silverman Adobe STAT+ | AI leads the way as health tech funding inches toward a post-pandemic stability Experts say that signs like early-stage investment, investor interest in AI, and a flurry of IPOs are good news for health tech startups. By Mario Aguilar Opinion: The ethical implications of Elon Musk's unorthodox approach to medical science Neuralink has unsettled many scientists rooted in peer-review publishing. Brain-computer interface development flouted norms of science. By Anna Wexler

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser